Uppsala Reports editor
@UMCGlobalSafety
A patient’s perspective can lead to new insights that traditional research may overlook. Yet how may we best harness their perspective to improve patient outcomes?
In this special long-reads episode, Manal Younus elaborates on her work on patient engagement, and how their perspective impacts drug safety monitoring and pharmacovigilance. Stay tuned for their discussion after the article, which goes into detail on how healthcare providers can more effectively engage patients, how patients themselves can become more involved in drug safety monitoring, and how the patient’s voice impacted pharmacovigilance of a specific drug: valproate.
This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance news site, brought to you in audio format. Find the original article here. Subscribe by visiting the Drug Safety Matters website.
Uppsala Reports editor
@UMCGlobalSafety
What if risk management began earlier? DRMPs serve as a framework for safety thinking in clinical development and support better benefit–risk decision-making.
04 March 2026
Despite focusing on different species, human and veterinary pharmacovigilance share many goals and approaches, offering opportunities for mutual enhancement of the two disciplines.
06 November 2025
Safety systems do not need to be complex to be effective. Shanthi Pal explains the thinking behind the Global Smart Pharmacovigilance Strategy, and how it can be implemented.
17 December 2025